Cargando…

Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER)

Detalles Bibliográficos
Autores principales:	Codoni, Greta, Gracia Villamil, Maria Alejandra, Stättermayer, Albert, Castiella, Agustin, Schramm, Christoph, Weltzsch, Jan-Philipp, Sebode, Marcial, Bernsmeier, Christine, Karnsakul, Wikrom, Lleo, Ana, Gevers, Tom, Kupcinskas, Limas, Hernandez, Nélia, Cerny, Andreas, Ghielmetti, Michele, Vergani, Diego, Mieli-Vergani, Giorgina, Bandera, Jose Pinazo, Lucena, Maria Isabel, Andrade, Raul J., Zen, Yoh, Taubert, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:	POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252395/ http://dx.doi.org/10.1016/S0168-8278(22)00984-9

Ejemplares similares

Autoimmune hepatitis diagnosed after COVID-19 vaccination. Results from the spanish registry for autoimmune and cholestatic hepatitis
por: Barreira, Ana, et al.
Publicado: (2022)

Correction: Sakulsaengprapha et al. Applicability of International Autoimmune Hepatitis Group (IAIHG) Scoring System for Autoimmune Hepatitis in Pediatrics. Biology 2023, 12, 479
por: Sakulsaengprapha, Vorada, et al.
Publicado: (2023)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

Update on Autoimmune Hepatitis
por: Liberal, Rodrigo, et al.
Publicado: (2015)

Autoimmmune hepatitis
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2021)

Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
por: Codoni, Greta, et al.
Publicado: (2022)

COVID-19 vaccine induced autoimmune hepatitis-a first case series from India
por: Iyengar, Sowmya, et al.
Publicado: (2022)

HLA, gut microbiome and hepatic autoimmunity
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2022)

Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2021)

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
por: Ghielmetti, Michele, et al.
Publicado: (2021)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
por: Pape, Simon, et al.
Publicado: (2020)

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
por: Jorgensen, Kristin, et al.
Publicado: (2022)

Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2017)

Environmental risk factors are associated with autoimmune hepatitis
por: Lammert, Craig, et al.
Publicado: (2021)

Extrahepatic autoimmune diseases in autoimmune hepatitis: Effect on mortality
por: Birn‐Rydder, Rasmine, et al.
Publicado: (2022)

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

A Study of Molecular Mimicry and Immunological Cross-reactivity between Hepatitis B Surface Antigen and Myelin Mimics
por: Bogdanos, Dimitrios-Petrou, et al.
Publicado: (2005)

Managing pediatric hepatitis C: current and emerging treatment options
por: Karnsakul, Wikrom, et al.
Publicado: (2009)

Antibodies to soluble liver antigen and α-enolase in patients with autoimmune hepatitis
por: Bogdanos, Dimitrios-Petrou, et al.
Publicado: (2004)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Post-COVID-19 cholangiopathy: does SARS-CoV-2 play a relevant role in histopathological findings?
por: de Almeida e Borges, Valéria Ferreira, et al.
Publicado: (2022)

Cholangiopathy after severe COVID-19: what do we know so far?
por: de Almeida e Borges, Valéria Ferreira, et al.
Publicado: (2022)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Autoimmune Liver Disease: News and Perspectives
por: Mieli-Vergani, Giorgina, et al.
Publicado: (2011)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
por: Rüther, Darius Ferenc, et al.
Publicado: (2022)

Pregnane-X-Receptor Controls Hepatic Glucuronidation During Pregnancy and Neonatal Development in Humanized UGT1 Mice
por: Chen, Shujuan, et al.
Publicado: (2012)

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+)-taurocholate cotransporting polypeptide knockout mice
por: Slijepcevic, Davor, et al.
Publicado: (2015)

Applicability of International Autoimmune Hepatitis Group (IAIGH) Scoring System for Autoimmune Hepatitis in Pediatrics
por: Sakulsaengprapha, Vorada, et al.
Publicado: (2023)

Real-world management of juvenile autoimmune liver disease
por: de Boer, Y S, et al.
Publicado: (2018)

Hepatitis D‐associated hospitalizations in the United States: 2010–2018
por: Wasuwanich, Paul, et al.
Publicado: (2022)

Hepatitis Monthly, an International Journal in the Field of Hepatology
por: Rezaee-Zavareh, Mohammad Saeid, et al.
Publicado: (2016)

The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic
por: Eyice, Deniz, et al.
Publicado: (2023)

A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction
por: An, Ping, et al.
Publicado: (2020)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020)

Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation
por: Lytvyak, Ellina, et al.
Publicado: (2021)

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
por: Radford‐Smith, Daniel E., et al.
Publicado: (2022)

Symptom patterns in the daily life of PSC patients
por: van Munster, Kim N., et al.
Publicado: (2022)

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
por: De Vincentis, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bsu07rudscngkserpk70fstv0a